| Aknologiaa vs King | 57–13 | 81.43% |
| Aknologiaa vs Jin | 36–17 | 67.92% |
| Aknologiaa vs Heihachi | 28–15 | 65.12% |
| Aknologiaa vs Hwoarang | 23–13 | 63.89% |
| Aknologiaa vs Kazuya | 27–9 | 75.00% |
| Aknologiaa vs Bryan | 23–10 | 69.70% |
| Aknologiaa vs Asuka | 21–11 | 65.62% |
| Aknologiaa vs Alisa | 18–8 | 69.23% |
| Aknologiaa vs Yoshimitsu | 16–9 | 64.00% |
| Aknologiaa vs Paul | 10–11 | 47.62% |
| Aknologiaa vs Dragunov | 14–7 | 66.67% |
| Aknologiaa vs Lee | 10–9 | 52.63% |
| Aknologiaa vs Law | 13–5 | 72.22% |
| Aknologiaa vs Lars | 14–3 | 82.35% |
| Aknologiaa vs Raven | 4–13 | 23.53% |
| Aknologiaa vs Xiaoyu | 8–8 | 50.00% |
| Aknologiaa vs Steve | 11–4 | 73.33% |
| Aknologiaa vs Reina | 9–2 | 81.82% |
| Aknologiaa vs Feng | 7–3 | 70.00% |
| Aknologiaa vs Jun | 7–3 | 70.00% |
| Aknologiaa vs Devil Jin | 5–4 | 55.56% |
| Aknologiaa vs Claudio | 8–1 | 88.89% |
| Aknologiaa vs Clive | 3–6 | 33.33% |
| Aknologiaa vs Anna | 4–5 | 44.44% |
| Aknologiaa vs Lili | 7–1 | 87.50% |
| Aknologiaa vs Leroy | 8–0 | 100.00% |
| Aknologiaa vs Lidia | 8–0 | 100.00% |
| Aknologiaa vs Fahkumram | 8–0 | 100.00% |
| Aknologiaa vs Nina | 6–1 | 85.71% |
| Aknologiaa vs Eddy | 4–3 | 57.14% |
| Aknologiaa vs Azucena | 5–0 | 100.00% |
| Aknologiaa vs Victor | 1–4 | 20.00% |
| Aknologiaa vs Zafina | 2–1 | 66.67% |
| Aknologiaa vs Shaheen | 2–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.